San Daniele del Friuli - May 9, 2024 | Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced today the opening of a new production plant at their San Daniele, Italy location, previously part of LimaCorporate S.p.A. (“Lima”), which Enovis acquired in January 2024. The new facility will double production capacity and create more than 100 new jobs, bringing positive impacts to the local and regional Italian economies.
The grand opening ceremony included the attendance of regional and national officials, along with Enovis senior leadership and employees. The event also marks the beginning of work on a new logistics center which enhances the company’s global reach and capability to best serve healthcare providers and their patients worldwide.
“We take immense pride in the inauguration of our new production plant,” said Luca Vozzi, Vice President of Operations for Enovis International Surgical. “With the increased square footage, state-of-the-art manufacturing equipment and additional team members, we are well positioned to elevate our production capacity and continue our growth as a global medical technology leader.”
Enovis is committed to continuing investments in the Friuli Venezia Giulia region over the next ten years, including the construction of third new building. With the newly inaugurated factory, production will increase from the current 750,000 units to more than 1.5 million per year, leading to a subsequent demand for around 100 new employees in the region. The investment in San Daniele will also benefit the company’s Sicilian plant located in Calatafimi, Segesta.
"Innovation is our company's driving force, and there is a growing demand for our surgical solutions around the world," added Benjamin Reinmann, President of Enovis International Surgical. "The addition of the plant and logistics center in San Daniele will expand Enovis’ ability to deliver pioneering medical technology along the orthopedic continuum of care and improve patient outcomes – our ultimate goal.”
To learn more about Enovis, visit www.enovis.com.
About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Media Contact
Katie Sweet
Vice President, Corporate Communications
Enovis Corporation
Katie.sweet@enovis.com